脳震盪後のバッファロー脳震盪トレッドミルテスト (BCTT) と修正動的運動テスト (mEXiT) の違い
バッファロー脳震盪トレッドミルテスト(BCTT)プロトコルと脳震盪後の修正動的運動テスト(mEXiT)の間の症状誘発と生理学的反応の比較
This study aims to compare symptom provocation, physiologic response, and rate of perceived (RPE) between the Buffalo Concussion Treadmill Test (BCTT) and a Modified Dynamic Exertion (mEXiT) test after sport related concussion in adolescents aged 14-17. Participants will be enrolled at their initial concussion clinical visit within 14 days of their injury, and randomly assigned to either the BCTT or mEXiT group. Participants will complete a single visit.
調査の概要
詳細な説明
The Buffalo Concussion Treadmill Test is a well established test to determine intensity of exercise without significant symptoms provocation after sport related concussion.
This study will help determine if there is a difference in type of symptom response between the two tests, due to the dynamic changes of direction and strain on the vestibular system with the m-EXiT group. The investigators hypothesize there will not be a significant difference between the two groups in time to clearance to return to sport despite allowing for higher symptoms earlier on in recovery.
High school athletes who have been diagnosed with a sport-related concussion will be randomly assigned to complete either the BCTT or the modified dynamic EXiT test (m-EXiT). The BCTT group will follow the established protocol and exercise to an increase of 2/10 symptoms on a visual analog scale (VAS) or 17/20 on rate of perceived effort (RPE) scale. The m-EXiT test will complete a shortened version of the dynamic EXiT test, but will stop if participants have an increase of greater than 4 points of headache, dizziness or nausea or RPE of 17/20. Symptoms, heart rate, and RPE will be measured through out both tests as well as Post-Concussion Symptom Scale (PCSS), Vestibular Ocular Motors Screening (VOMS), blood pressure and heart rate will be administered before and after testing. The time (in days) to recovery, will also be recorded from the medical record to determine if there is a difference between the two groups.
The primary outcome for the study will be symptoms post test and heart rate. Secondary measures include: Post Concussion Symptom Score (PCSS), Clinical Profiles Screening (CP-Screen), Vestibular Ocular Motor Screening (VOMS), Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder - 7 (GAD-7) and blood pressure. These will be collected at one visit with participants, there are no follow-up or subsequent visits for this study.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Pennsylvania
-
Pittsburgh、Pennsylvania、アメリカ、15203
- UPMC/Univ of Pgh Sports Medicine Concussion Research Program
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Diagnosed with a sport related concussion within 14 days of injury
- Participants referred to exertion therapy after a trained clinician from University of Pittsburgh Medical Center (UPMC) Sports Medicine Concussion Program has interpreted neurocognitive, vestibular, and clinical interview outcomes and determined the participant is capable of completing structured exercise.
Exclusion Criteria:
- Medically cleared from a previous concussion within the past 6 months
- More than 2 previous concussions (excluding current injury)
- History of brain surgery or traumatic brain injury (TBI) (based on Glasgow Coma Scale of <13)
- History of neurological disorder (seizure disorder, epilepsy, brain tumors or malformations)
- Current history of pre-existing vestibular disorder or oculomotor condition
- Currently taking antidepressant, anticoagulant, beta-blocker, or anticonvulsant prescription medications
- Incapable of treadmill running up to 5.5 miles per hour (mph) and 4.5 mph for males and females respectively (self-reported).
- Diagnosed with a cardiac, peripheral, or cerebrovascular disease (type 1 or 2 diabetes, or renal disease.
- Experienced chest pain or shortness of breath while at rest or with mild exertion.
- Lose balance because of dizziness or have lost consciousness (aside from concussion) from exertion
- Currently have (or have had within the past 12 months) a bone, joint, or soft tissue (muscle, ligament, or tendon) problem that could be made worse by physical activity
- Been told by a doctor to only conduct physical activity under medical supervision.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:ヘルスサービス研究
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ:Buffalo Concussion Treadmill Test (BCTT)
Participants in this group will complete the Buffalo Concussion Treadmill Test (BCTT). This involves individuals walking at 5.8 km/hr. (3.6 mph) at a 0.0% incline (5.1 km/hr. [3.2 mph] if below 5' 10" tall), the treadmill incline is increased 1 degree each minute for the first 15 minutes, then speed increased 0.64 km/hr. (0.4 mph) each minute thereafter. |
Participants will complete the Buffalo Concussion Treadmill Test, which involves individuals walking at 5.8 km/hr. (3.6 mph) at a 0.0% incline (5.1 km/hr. [3.2 mph] if below 5' 10" tall), the treadmill incline is increased 1 degree each minute for the first 15 minutes, then speed increased 0.64 km/hr. (0.4 mph) each minute thereafter. |
|
実験的:Modified EXiT Test (mEXiT)
Participants in this group will complete the modified EXiT test (mEXiT). Participants will complete a 12 minute treadmill interval program followed by a dynamic circuit (10 squat jumps, 10 side to side push ups and 10 medicine ball rotations), jump ball toss, zig zag agility and arrow agility. Parameters will be recorded the same as the established dynamic EXiT test; heart rate and RPE will be recorded at 0, 2, 6:30 and 12 minutes of the treadmill program as well as after the second trial of each activity. The time to complete two trials of the zig zag agility and arrow agility will also be recorded. |
The modified EXiT test will complete a 12 minute treadmill interval program followed by a dynamic circuit (10 squat jumps, 10 side to side push ups and 10 medicine ball rotations), jump ball toss, zig zag agility and arrow agility. Parameters will be recorded the same as the established dynamic EXiT test; heart rate and RPE will be recorded at 0, 2, 6:30 and 12 minutes of the treadmill program as well as after the second trial of each activity. The time to complete two trials of the zig zag agility and arrow agility will also be recorded. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Physiological response to dynamic or aerobic test (HEART RATE)
時間枠:Visit 1 (baseline) (pre, during, and post testing) 90 minutes
|
Participants will have their heart rate taken before the exercise protocol, then monitored throughout the test and after they complete the BCTT or mEXiT. |
Visit 1 (baseline) (pre, during, and post testing) 90 minutes
|
|
Physiological response to dynamic or aerobic test (SYMPTOM PROVOCATION)
時間枠:Visit 1 (baseline) (pre and post testing) 90 minutes
|
Participants will report on a Likert scale ranging from 0-10 (10 being severe) for headache, dizziness, and nausea, and provide a rating of perceived exertion (RPE) on a Borg scale ranging from 6 to 20 before and after completion of the BCTT or mEXiT. |
Visit 1 (baseline) (pre and post testing) 90 minutes
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Post Concussion Symptom Scale
時間枠:Visit 1 Baseline (60-90 minutes), participants only complete one visit
|
Participants rate on a 7 point Likert scale the presence and severity of 22 common concussion-related symptoms, including, but not limited to headache, dizziness, confusion, fogginess. The scale is 0-6 (0=none, 1-2=mild, 3-4=moderate, 5-6=severe). Higher the score, the more symptoms participant is reporting. |
Visit 1 Baseline (60-90 minutes), participants only complete one visit
|
|
Patient Health Questionnaire (PHQ-9)
時間枠:Visit 1 Baseline (60-90 minutes), participants only complete one visit
|
The PHQ-9 is a 9 item questionnaire that assesses the presence and severity of depression over the last 2-weeks. Total score ranges from 1-27, with higher scores indicating higher level of depression. Scale is 0-4 (0=not at all, 1=several days, 2=more than half the days, 3=nearly every day). Higher scores indicate worse reporting of issues. |
Visit 1 Baseline (60-90 minutes), participants only complete one visit
|
|
Generalized Anxiety Disorder (GAD-7)
時間枠:Visit 1 Baseline (60-90 minutes), participants only complete one visit
|
The GAD-7 is a seven item self-reported questionnaire that measures severity of symptoms regarding anxiety. Responses are 0 = not at all, 1 = several days, 2= more than half the days, and 3 = nearly every day. Higher scores are indicative of higher anxiety (0-4 = minimal anxiety, 5-9= mild anxiety, 10-14 =moderate anxiety, 15-21 = severe anxiety (higher scores indicate higher level of reported anxiety). |
Visit 1 Baseline (60-90 minutes), participants only complete one visit
|
|
Vestibular Ocular Motor Screening (VOMS)
時間枠:Visit 1 Baseline (pre and post testing 60-90 minutes), participants only complete one visit
|
Participants will complete a VOMS assessment which will take approximately 5 minutes. Prior to screening, the participant reports baseline symptoms (headache, dizziness, nausea, fogginess) on a scale from 0 to 10. Then the participant performs different eye movements that include: smooth pursuits, saccades (horizontal & vertical), convergence, vestibular ocular reflex (VOR [horizontal & vertical]), visual motor sensitivity (VMS) and again rates his/her symptoms (headache, dizziness, nausea, fogginess) on a Likert scale from 0 to 10. Abnormal findings or provocation of symptoms with any test may indicate dysfunction. This will be completed by a clinician or researcher. This procedure will be repeated after BCTT and mEXiT protocol on the same day. Higher scores indicate worse symptoms. |
Visit 1 Baseline (pre and post testing 60-90 minutes), participants only complete one visit
|
|
Clinical Profiles Screening (CP-Screen)
時間枠:Visit 1 Baseline (60-90 minutes), participants only complete one visit
|
The CP Screen is a 29 item self-report, clinical profiles based symptom inventory that measures five concussion clinical profiles: 1) anxiety/mood, 2) cognitive/fatigue, 3) migraine, 4) ocular, 5) vestibular; and two modifying factors, sleep and cervical. Patients rate the severity of their symptoms as none = 0, mild = 1, moderate = 2, or severe =3. Scores are totaled across the clinical profiles and symptom modifiers. The measure also yields a CP-Screen total raw score ranging from (0-87) with higher scores reflecting more symptoms. |
Visit 1 Baseline (60-90 minutes), participants only complete one visit
|
|
Blood Pressure
時間枠:Visit 1 Baseline (pre and post testing 60-90 minutes), participants only complete one visit
|
Participants blood pressure will be taken same-day, before and after the BCTT or mEXiT test (both systolic and diastolic BP will be recorded with all measurements). |
Visit 1 Baseline (pre and post testing 60-90 minutes), participants only complete one visit
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Anthony P Kontos, PhD、University of Pittsburgh
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- STUDY23070079
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
De-identified data may be shared with other researchers who sent a request to to the study investigators. The data can be used for any analysis purpose, including publications or presentations.
After de-identification, all of the individual participant data collected during the trial will be available for sharing.
IPD 共有時間枠
During and after study completion. No end date
IPD 共有アクセス基準
Researchers will need to contact the study investigators and ask for access to available de-identified data.
IPD 共有サポート情報タイプ
- STUDY_PROTOCOL
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。